I'm glad we secured that funding late last year, even if it coincided with a drop in share price. We have at least two years of cash runway. I know expenses can balloon in biotech companies but I think we are on track to find out how effect the anti-infectives are before we need further capital (If at all)
I'm glad we secured that funding late last year, even if it...
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
29.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $83.62M | |||
| Open | High | Low | Value | Volume |
| 29.0¢ | 30.0¢ | 29.0¢ | $12.61K | 42.50K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 22627 | 29.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 29.5¢ | 320 | 1 |
View Market Depth
| Last trade - 12.57pm 25/06/2025 (20 minute delay) ? |
| RCE (ASX) Chart |